AIC
LGND icon

Ameritas Investment Company’s Ligand Pharmaceuticals LGND Stock Holding History

Ameritas Investment Company’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$324K Hold
3,727
– – 0.02% 540
2021
Q2 		$305K Buy
3,727
+80
+2% +$6.66K 0.01% 563
2021
Q1 		$347K Hold
3,647
– – 0.03% 431
2020
Q4 		$226K Buy
+3,647
New +$208K 0.04% 374
2020
Q2 		– Sell
-11
Closed -$1K – 1043
2020
Q1 		$1K Buy
+11
New +$623 ﹤0.01% 1670
2019
Q2 		– Sell
-11
Closed -$1K – 573
2019
Q1 		$1K Sell
11
-550
-98% -$41.7K ﹤0.01% 900
2018
Q4 		$47K Buy
+561
New +$59.8K 0.01% 600

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Ameritas Investment Company's LGND Position: Q3 2021 in Review

Ameritas Investment Company held its Ligand Pharmaceuticals (LGND) position steady in Q3 2021 at 3,727 shares worth $324K. The position accounts for 0.02% of the portfolio, ranked #540.

Ameritas Investment Company first reported a position in LGND in Q4 2018 and has held it in 7 quarters since. The position peaked at $347K in Q1 2021. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.

  • Ameritas Investment Company held 3,727 shares of Ligand Pharmaceuticals worth $324K as of Q3 2021.
  • Ameritas Investment Company left its Ligand Pharmaceuticals share count unchanged in Q3 2021.
  • Ligand Pharmaceuticals made up 0.02% of Ameritas Investment Company's portfolio in Q3 2021, its #540 holding.
  • Ameritas Investment Company first reported a position in Ligand Pharmaceuticals in Q4 2018 and has held it in 7 quarters since.
  • Ameritas Investment Company's Ligand Pharmaceuticals position peaked at $347K in Q1 2021.
  • 207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.